Bilcare Ltd.

BSE: BI526853ISIN INE986A01012

Healthcare
Healthcare Research, Analytics & Technology

Share price

₹77.69-4.04 (-4.94%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹114.55
52W low: ₹50.00
Off 52W high: -32.18%
1M return: -18.02%
3M return: +22.35%
6M return: +24.40%
1Y return: -25.62%
20D avg volume: 6,022
50 DMA: ₹93.27
200 DMA: ₹70.63

Key ratios Consolidated

Market cap: ₹182.92 Cr
Current price: ₹77.69
52W high / low: ₹114.55 / ₹50.00
Face value: ₹10.00
P/E: 16.51
P/B: 1.02
EPS (TTM): ₹4.71
Book value / share: ₹75.96
ROE: —
ROCE: 9.20%
Operating margin: —
Net margin: —
Debt / equity: 8.37
Net debt: ₹615.83 Cr
Interest cover: 0.70
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 64.3 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	248.43	225.86	187.66	181.32	178.20	186.36	194.03	198.13	201.74	194.14	—
	3.53	1.75	14.46	5.14	4.32	6.08	7.37	3.44	3.91	3.74	—
	251.96	227.61	202.12	186.46	182.52	192.44	201.40	201.57	205.65	197.88	—
	249.98	211.03	193.20	197.28	206.07	205.40	216.71	218.70	228.81	207.57	—
	167.05	142.68	124.21	122.57	119.07	128.32	129.71	133.72	139.61	131.39	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	22.54	19.77	19.32	21.34	19.28	20.02	21.14	21.65	19.93	18.38	—
	19.73	18.08	17.69	17.04	19.06	18.55	18.49	19.48	23.68	20.85	—
	4.13	4.11	4.78	11.93	12.23	11.56	11.58	11.74	11.04	11.52	—
	37.72	29.87	34.77	27.75	27.17	29.56	35.60	33.51	30.51	30.39	—
	1.98	16.58	8.92	-10.82	-23.55	-12.96	-15.31	-17.13	-23.16	-9.69	—
	0.00	-1.74	-2.00	-1.80	0.00	0.00	13.79	-9.91	-9.93	0.00	—
	1.98	14.84	6.92	-12.62	-23.55	-12.96	-1.52	-27.04	-33.09	-9.69	—
	0.91	-0.13	0.93	0.19	-0.23	-3.20	-6.56	10.79	3.16	5.33	—
	1.07	14.97	7.85	-12.81	-23.32	-9.76	5.04	-16.25	-29.93	-15.02	—
	1.75	5.39	5.68	-2.53	-5.25	-1.59	4.48	-3.05	-6.81	-2.71	—
Key metrics
	25.84	37.03	29.39	16.35	7.74	17.15	28.55	4.18	1.63	22.68	—
	10.40%	16.40%	15.70%	9.00%	4.30%	9.20%	14.70%	2.10%	0.80%	11.70%	—
	0.40%	6.60%	4.20%	-7.10%	-13.10%	-5.20%	2.60%	-8.20%	-14.80%	-7.70%	—
	4.10%	—	4.50%	—	-0.40%	—	1.60%	—	—	—	—
	39.40%	21.20%	-3.30%	-8.50%	-11.70%	-4.00%	—	—	—	—	—
	104.60%	253.40%	55.80%	21.20%	22.10%	35.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	843.27	733.54	788.04	—
	24.88	30.00	18.46	—
	868.15	763.54	806.50	—
	851.49	781.20	871.79	—
	556.51	494.17	535.89	—
	0.00	0.00	0.00	—
	82.97	79.96	81.07	—
	72.54	72.34	82.50	—
	24.95	19.75	45.88	—
	130.11	119.25	128.58	—
	16.66	-17.66	-65.29	—
	-5.54	-3.80	-6.05	—
	11.12	-21.46	-71.34	—
	1.90	4.17	-15.18	—
	11.08	-17.29	-56.16	—
	10.29	0.73	-12.22	—
Key metrics
	108.61	70.63	57.04	—
	12.88%	9.60%	7.20%	—
	1.31%	-2.40%	-7.10%	—
	—	9.20%	1.00%	—
	11.44%	-6.90%	—	—
	—	69.20%	—	—
	—	116.96	62.41	—
	—	-7.39	-1.51	—
	—	8.37	1.16	—
	—	615.83	667.61	—
	—	64.3	70.5	—
Balance sheet
	—	842.83	1,417	—
	—	289.25	278.55	—
	—	4.61	14.14	—
	—	108.04	118.89	—
	—	114.84	117.12	—
	—	13.09	12.64	—
	—	425.33	932.53	—
	—	93.75	83.68	—
	—	292.16	339.22	—
	—	620.44	681.75	—
	—	160.42	218.31	—
	—	460.02	463.44	—
	—	74.14	589.76	—
Cash flow
	—	127.79	84.99	—
	—	-5.90	81.16	—
	—	-132.31	-169.25	—
	—	10.83	22.58	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	1.93	1.94	1.20	1.73	1.85	2.07	4.13	3.36	2.76	4.87	—
	4.88	4.36	3.82	5.54	3.45	6.72	6.45	3.78	3.78	3.84	—
	6.81	6.30	5.02	7.27	5.30	8.79	10.58	7.14	6.54	8.71	—
	3.50	3.65	9.93	4.33	4.10	4.30	6.36	4.78	9.30	7.08	—
	0.39	0.53	0.12	0.46	0.52	0.67	0.34	0.71	0.61	2.17	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	1.29	1.20	0.78	1.42	1.38	1.29	0.73	1.48	1.50	1.89	—
	0.10	0.12	0.14	0.15	0.17	0.14	0.06	0.12	3.04	0.63	—
	0.60	0.60	0.61	0.71	0.72	0.68	0.60	0.77	0.77	0.73	—
	1.12	1.20	8.28	1.59	1.31	1.52	5.31	1.69	3.38	1.66	—
	3.31	2.65	-4.91	2.94	1.20	4.49	4.22	2.36	-2.76	1.63	—
	-0.90	-1.74	-2.08	-0.08	0.00	0.00	0.00	—	—	—	—
	2.41	0.91	-6.99	2.86	1.20	4.49	4.22	2.36	-2.76	1.63	—
	0.91	-0.13	0.64	0.15	0.16	0.90	0.86	0.56	0.19	0.23	—
	1.50	1.04	-6.35	2.71	1.04	3.59	3.36	1.80	-2.57	1.40	—
	0.64	0.44	-2.70	1.15	0.44	1.52	1.43	0.76	-1.09	0.59	—
Key metrics
	3.11	1.63	-6.24	3.72	2.09	5.31	4.88	3.25	1.05	2.99	—
	161.10%	84.00%	-520.00%	215.00%	113.00%	256.50%	118.20%	96.70%	38.00%	61.40%	—
	77.70%	53.60%	-529.20%	156.60%	56.20%	173.40%	81.40%	53.60%	-93.10%	28.70%	—
	0.60%	—	-1.60%	—	0.30%	—	1.00%	—	—	—	—
	4.30%	-6.30%	-70.90%	-48.50%	-33.00%	-57.50%	—	—	—	—	—
	44.20%	-71.00%	-289.00%	50.60%	140.50%	156.40%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	6.80	6.85	15.12	—
	18.60	19.53	17.85	—
	25.40	26.38	32.97	—
	21.41	22.66	27.52	—
	1.50	1.77	4.61	—
	0.00	0.00	0.00	—
	4.69	4.87	5.57	—
	0.51	0.60	3.85	—
	2.52	2.72	2.87	—
	12.19	12.70	10.61	—
	3.99	3.72	5.45	—
	-4.80	-2.16	0.00	—
	-0.81	1.56	5.45	—
	1.57	0.57	1.46	—
	-1.10	0.99	3.99	—
	-0.47	0.42	1.70	—
Key metrics
	2.22	4.88	12.17	—
	32.65%	71.20%	80.50%	—
	-16.18%	14.50%	26.40%	—
	—	0.50%	2.10%	—
	-40.40%	-54.70%	—	—
	-111.24%	-75.20%	—	—
	—	10.45	2.20	—
	—	11.69	0.59	—
	—	0.03	0.03	—
	—	11.47	8.18	—
	—	5.9	44.4	—
Balance sheet
	—	455.12	452.21	—
	—	4.31	18.84	—
	—	0.40	2.64	—
	—	2.04	3.41	—
	—	0.18	0.38	—
	—	0.45	0.95	—
	—	55.58	56.37	—
	—	2.11	1.95	—
	—	19.40	16.44	—
	—	11.87	10.82	—
	—	0.47	0.27	—
	—	11.40	10.55	—
	—	420.89	419.68	—
Cash flow
	—	11.57	2.34	—
	—	-14.05	2.95	—
	—	0.24	-3.84	—
	—	1.12	0.14	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -40.40%
Profit YoY (TTM): -111.24%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +11.44%
Profit YoY (TTM): +125.02%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 30.01%

Quarter	September 2026	June 2026
Promoter %	30.01%	30.01%

Holder	Type	Holding	Previous	Change
Mohan Harakchand Bhandari	Promoter	24.87%	24.87%	0.00%
Monument Pte Limited	Public	16.44%	16.44%	0.00%
Guttikonda Vara Lakshmi	Public	13.59%	14.73%	-1.14%
Nutan Mohan Bhandari	Promoter	5.12%	5.12%	0.00%
Guttikonda Rajasekhar	Public	3.39%	2.20%	+1.19%
Sharad Mohanlal Bhatevara	Public	1.64%	1.64%	0.00%
Rajendra Bhagirath Tapadia	Public	1.06%	1.06%	0.00%
Chhaganbhai Parsottambhai Patel Huf	Public	1.03%	1.03%	0.00%
Ankita Jayesh Kariya	Promoter	0.02%	0.02%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Syngene International Limited	16,841	417.20	90.49	8.40%	-5.99% TTM	-60.25% TTM	-35.44%
Indegene Limited	14,870	617.05	36.17	15.40%	+35.84% TTM	-7.78% TTM	+14.61%
Suven Life Sciences Ltd.	7,803	276.15	-22.14	-46.50%	+17.29% TTM	-91.30% TTM	+40.18%
Vimta Labs Ltd.	2,230	498.80	—	—	+4.90% TTM	+48.48% TTM	-24.58%
NOVELIX PHARMACEUTICALS LIMITED S	194	68.00	53.54	6.70%	+179.89% TTM	+535.09% TTM	+29.52%
Bilcare Ltd.	183	77.69	16.51	9.20%	+11.44% TTM	+125.02% TTM	-25.62%
TAKE LIMITED S	170	11.47	29.00	11.10%	-15.35% TTM	+124.35% TTM	-52.11%
Jeevan Scientific Technology Limited	164	81.70	32.02	4.80%	+66.05% TTM	+222.49% TTM	+30.72%
GlobalSpace Technologies Limited	99	28.84	29.21	5.00%	+37.21% TTM	+398.53% TTM	+63.12%
Adeshwar Meditex Limited S	27	18.80	21.36	6.00%	—	—	+1.62%
Vanta Bioscience Limited	14	20.39	—	1.50%	—	—	-5.86%

Filings & corporate actions

Recent announcements

The Board of Directors has approved the Financial Results for quarter and half year ended September 30, 20263 Nov 2026 · Result / Financial Results
The Board of Directors of Bilcare Limited in their meeting held on Tuesday, 03 November 2026 have approved and taken on record Standalone and Consolidated Unaudited Financial Results of ....3 Nov 2026 · Board Meeting / Outcome of Board Meeting
Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Bilcare Limited has informed BSE that ....27 Oct 2026 · Board Meeting / Board Meeting
Update on Voluntary winding up of Bilcare INC -US19 Oct 2026 · Company Update / General
Change in Designation of Mr. Mohan Bhandari and Ms Kavita Bhansali15 Oct 2026 · Company Update / Change in Management
Bilcare Limited has submitted the Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations , 2018 for quarter ended 30 September 202613 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Voting Results of 39th Annual General Meeting and Scrutinizers Reports29 Sep 2026 · AGM/EGM / AGM
Intimation of Trading Window Closure for quarter and half year ended 30 September 202628 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Bilcare Limited has informed the exchange about Proceeding of 39th Annual General Meeting held on 26 September 202626 Sep 2026 · AGM/EGM / AGM
Bilcare Limited has submitted to Stock Exchange the Corrigendum to item No. 4 of the Notice of the 39th Annual General Meeting24 Sep 2026 · AGM/EGM / AGM
Bilcare Limited has submitted to Stock Exchange the Corrigendum to Item No. 4 of the Notice of the 39th Annual General Meeting24 Sep 2026 · AGM/EGM / AGM
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Guttikonda Anuradha & Others21 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Bilcare Limited has informed the Exchange about Newspaper Publication regarding dispatch of Notice of Annual General Meeting and Annual Report of 2025-26.7 Sep 2026 · Company Update / Newspaper Publication
Bilcare Limited has submitted Outcome of Board Meeting4 Sep 2026 · Others / Outcome without intimation
Bilcare Limited has submitted to the Exchange it''s Annual Report of 2025-264 Sep 2026 · Others / Reg. 34 (1) Annual Report
Bilcare Limited has submitted to the Exchnage Annual Report of 2025-26.4 Sep 2026 · AGM/EGM / AGM
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Guttikonda Rajasekhar & Others22 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Bilcare Limited has informed the Exchange about the Newspaper Publication of Quarterly Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June 2026.15 Aug 2026 · Company Update / Newspaper Publication
Bilcare Limited has informed the Exchange about the Voluntary winding up of wholly owned subsidiary.13 Aug 2026 · Company Update / General
Bilcare Limited has informed the Exchange about the appointment of Company Secretary, Compliance Officer and Key Managerial Personnel13 Aug 2026 · Company Update / Appointment of Company Secretary / Compliance Officer
Bilcare Limited has informed the Exchange aabout the Resignation of Company Secretary, Compliance Officer and Key Managerial Personnel13 Aug 2026 · Company Update / Resignation of Company Secretary / Compliance Officer
Bilcare Limited has informed the Exchange about the appointment of Mr. Mohan Bhandari as an Executive Director of the Company and reappointment of Ms. Kavita Bhansali as Executive Director ....13 Aug 2026 · Company Update / Change in Management
Bilcare Limited has informed the Exchange about Standalone & Consolidated Unaudited Financial Results for the quarter ended on 30 June 2026 along with Limited Review Report issued by Statutory ....13 Aug 2026 · Result / Financial Results
Bilcare Limitedhas informed the Exchange about the outcome of Board Meeting.13 Aug 2026 · Result / Financial Results
Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financial Results (Standalone ....7 Aug 2026 · Board Meeting / Board Meeting
Bilcare Limited has submitted the Scrutinizer''s Report and Voting Results regarding Postal Ballot conducted.24 Jul 2026 · AGM/EGM / Postal Ballot
Bilcare Limited has submitted the Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 June 2026.7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Bilcare Limited has submitted intimation towards closure of trading window.26 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Bilcare Limited has informed the Exchange about Newspaper Publication regarding Postal Ballot Notice and Remote e-voting.23 Jun 2026 · Company Update / Newspaper Publication
Bilcare Limited has informed the Exchange about Notice of Postal Ballot.22 Jun 2026 · AGM/EGM / Postal Ballot
Bilcare Limited has submitted to the Exchange about the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regualtions, 2015 - Order of Hon''ble ....12 Jun 2026 · Company Update / General
Bilcare Limited has submitted to the Exchange about the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.4 Jun 2026 · Company Update / General
Newspaper publication of Audited Financial Results (Standalone and Consolidated) for the Quarter and Year Ended 31st March 2026.1 Jun 2026 · Company Update / Newspaper Publication
Bilcare Limited has submitted the Annual Secretarial Compliance Report for the year ended on 31 March 2026.30 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Bilcare Limited has informed the Exchange about the following: a) Redemption of Preference Shares and b) Conversion of Warrants and Allotment of Equity Shares30 May 2026 · Company Update / General
Bilcare Limited has informed the Exchnage that the Board of Directors in their Meeting held on 29 May 2026 have approved Audited Financial Results (Standalone and Consolidated) for the ....30 May 2026 · Result / Financial Results
Bilcare Limited has informed the Exchange about the outcome of Board Meeting held on 29 May 202630 May 2026 · Board Meeting / Outcome of Board Meeting
Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial Results (Standalone ....22 May 2026 · Board Meeting / Board Meeting
Bilcare Limited has informed the Exchange that the Non - applicability of Large Corporate Category.29 Apr 2026 · Company Update / General
Bilcare Limited has informed the Exchange about the Cessation due to Completion of Second Term as an Independent Director Mrs. Madhuri Vaidya effective from end of business hours on 26 April 2026.25 Apr 2026 · Company Update / Cessation

Board meetings

3 Nov 2026 Board Meeting - Financial Results
13 Aug 2026 Board Meeting - Financial Results